Scientists have developed a new, safe and effective way to infect volunteers with the parasite that causes leishmaniasis and measure the body's immune response, bringing a vaccine for the neglected ...

A phase 1 clinical trial testing the safety of a leishmaniasis vaccine is set to begin in the coming months – the first vaccine created to protect against the disfiguring skin disease common in ...

Scientists have developed a new, safe and effective way to infect volunteers with the parasite that causes leishmaniasis and measure the body's immune response, bringing a vaccine for the neglected ...

Researchers say they have developed a novel, safe, and effective way to infect volunteers with the parasite that causes leishmaniasis and measure the body’s immune response, bringing a vaccine for the ...

A vaccine for leishmaniasis years in the making has been developed and approved for testing in humans, with clinical trials ...

Scientists have established the effectiveness of vaccines they developed to prevent the disfiguring skin disease leishmaniasis in animal studies, and Phase 1 human trial planning is in motion for the ...

Video and photos are available for download: New vaccine offers hope against growing tropical disease in U.S. Ohio State researchers develop a first-ever vaccine against leishmaniasis, which could ...

CLEVELAND, Ohio — Leishmaniasis is a disfiguring parasitic disease that affects millions of people globally, including in the United States. Currently, there is no vaccine to protect against the ...

A promising vaccine candidate against leishmaniasis, a parasitic disease also known as kala-azar, developed by researchers at Ohio State University in the United States, is offering fresh hope to ...

For many dog owners, a canine visceral leishmaniasis diagnosis for their pet can mean facing the painful decision of euthanasia. This zoonotic disease significantly impacts public health and can be ...

Shorter and less toxic treatment for people with visceral leishmaniasis is possible by combining drugs, a study published in Clinical Infectious Diseases shows. Combining Miltefosine (MF), the only ...